Xponance Inc. Has $840,000 Stock Holdings in Genpact Limited (NYSE:G)

Xponance Inc. boosted its position in shares of Genpact Limited (NYSE:GFree Report) by 8.0% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 19,566 shares of the business services provider’s stock after purchasing an additional 1,454 shares during the quarter. Xponance Inc.’s holdings in Genpact were worth $840,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. SRH Advisors LLC acquired a new stake in shares of Genpact during the fourth quarter worth about $26,000. Manchester Capital Management LLC bought a new stake in Genpact during the 4th quarter worth approximately $38,000. Smartleaf Asset Management LLC raised its holdings in Genpact by 416.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock worth $41,000 after buying an additional 783 shares during the period. UMB Bank n.a. lifted its stake in Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock valued at $52,000 after buying an additional 433 shares in the last quarter. Finally, J.Safra Asset Management Corp boosted its holdings in shares of Genpact by 38.8% in the fourth quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider’s stock valued at $69,000 after buying an additional 453 shares during the period. Institutional investors own 96.03% of the company’s stock.

Insiders Place Their Bets

In related news, SVP Piyush Mehta sold 12,000 shares of the business’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares in the company, valued at $6,475,125.06. The trade was a 7.35 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at $15,167,926.94. The trade was a 4.20 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on G shares. Needham & Company LLC raised their price objective on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a report on Friday, February 7th. TD Cowen raised Genpact from a “hold” rating to a “buy” rating and lifted their target price for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a “hold” rating to a “buy” rating and boosted their target price for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Finally, Mizuho lifted their price objective on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Six investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, Genpact presently has an average rating of “Hold” and an average target price of $48.44.

Read Our Latest Analysis on Genpact

Genpact Stock Performance

Shares of G stock opened at $49.93 on Tuesday. The stock has a market cap of $8.77 billion, a P/E ratio of 17.58, a P/E/G ratio of 1.84 and a beta of 1.16. The company has a fifty day moving average price of $50.38 and a two-hundred day moving average price of $44.78. Genpact Limited has a one year low of $30.23 and a one year high of $56.76. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85.

Genpact (NYSE:GGet Free Report) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, equities analysts predict that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th will be issued a dividend of $0.17 per share. This is an increase from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date is Tuesday, March 11th. This represents a $0.68 annualized dividend and a yield of 1.36%. Genpact’s dividend payout ratio (DPR) is currently 23.94%.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.